Oxidative Stress and Inflammation in Hepatic Diseases: Current and Future TherapyView this Special Issue
Research Article | Open Access
Yihan Zhang, Dongdong Yuan, Weifeng Yao, Qianqian Zhu, Yue Liu, Fei Huang, Jiayu Feng, Xi Chen, Yong Huang, Xinjin Chi, Ziqing Hei, "Hyperglycemia Aggravates Hepatic Ischemia Reperfusion Injury by Inducing Chronic Oxidative Stress and Inflammation", Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3919627, 16 pages, 2016. https://doi.org/10.1155/2016/3919627
Hyperglycemia Aggravates Hepatic Ischemia Reperfusion Injury by Inducing Chronic Oxidative Stress and Inflammation
Aim. To investigate whether hyperglycemia will aggravate hepatic ischemia reperfusion injury (HIRI) and the underlying mechanisms. Methods. Control and streptozotocin-induced diabetic Sprague-Dawley rats were subjected to partial hepatic ischemia reperfusion. Liver histology, transferase, inflammatory cytokines, and oxidative stress were assessed accordingly. Similarly, BRL-3A hepatocytes were subjected to hypoxia/reoxygenation (H/R) after high (25 mM) or low (5.5 mM) glucose culture. Cell viability, reactive oxygen species (ROS), and activation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB) were determined. Results. Compared with control, diabetic rats presented more severe hepatic injury and increased hepatic inflammatory cytokines and oxidative stress. HIRI in diabetic rats could be ameliorated by pretreatment of N-acetyl-L-cysteine (NAC) or apocynin. Excessive ROS generation and consequent Nrf2 and NF-κB translocation were determined after high glucose exposure. NF-κB translocation and its downstream cytokines were further increased in high glucose cultured group after H/R. While proper regulation of Nrf2 to its downstream antioxidases was observed in low glucose cultured group, no further induction of Nrf2 pathway by H/R after high glucose culture was identified. Conclusion. Hyperglycemia aggravates HIRI, which might be attributed to chronic oxidative stress and inflammation and potential malfunction of antioxidative system.
Hepatic ischemia reperfusion injury (HIRI) is a major cause for acute postoperative liver dysfunction and liver failure. It is common in major hepatic surgery including liver transplantation and partial hepatectomy. The mechanisms of HIRI consist of multiple complicated pathophysiological processes including mitochondrial energy exhaustion, excessive reactive oxygen species (ROS) production, calcium overload, leukocyte aggregation, cytokine release, and microcirculation dysfunction [1–5]. Of note, the outburst of oxidative and proinflammatory factors is crucial to initiating HIRI . During reperfusion, enormous ROS are generated due to sudden restoration of oxygen and exert direct deleterious effects on cells through lipid peroxidation, protein degradation, and DNA damage .
Diabetes is a major risk factor for many surgical complications [7–9]. It is particularly associated with poor prognosis of ischemia reperfusion (IR) injury. Many have reported that IR injury of heart, kidney, and neuron tissues tends to be more severe in diabetic patients [10–12]. Hyperglycemia is a major manifestation of diabetes and it contributes to the progression of many diabetic complications .
Hyperglycemia could increase basal ROS levels in cardiomyocytes, renal mesenchymal cells, and endothelial cells, resulting in a state of chronic oxidative stress [14–16]. The increase in baseline ROS generation has been reported to be an important factor to aggravate cardiac IR injury . Furthermore, chronic oxidative stress would diminish the protection of anesthetic preconditioning and ischemic preconditioning upon acute oxidative stress in IR [18, 19].
Chronic oxidative stress may promote the onset or progression of chronic liver diseases including nonalcoholic fatty liver disease (NAFLD), cirrhosis, hepatitis, and hepatic carcinoma, which if not treated properly are likely to advance to end-stage liver diseases requiring surgical intervention [20, 21]. However, little is known about the impact of chronic oxidative stress in diabetes on HIRI. The evidence of correlation between diabetes and negative outcome of HIRI is accumulating [22, 23]. For instance, the risk of liver graft failure is higher in diabetic patients compared with nondiabetic patients after liver transplant . Consistently, diabetes is a risk factor for unexpected readmission in patients receiving hepatic surgery . Since liver plays a central role in glucose metabolism, deterioration of liver function would in turn worsen diabetes . The underlying mechanisms of diabetes and poor outcome of hepatic surgery remain unknown.
As the incidence of diabetes rises rapidly , there is a growing need to focus on HIRI in diabetic patients. By establishing in vivo HIRI model on streptozotocin- (STZ-) induced type 1 diabetic rats and in vitro hypoxia/reoxygenation (H/R) model on hepatocytes, we intend to explore the impact of hyperglycemia or high glucose condition upon HIRI or H/R injury and the possible mechanisms.
2.1. Animal Models of Diabetes
This study was approved by the Animal Ethical and Welfare Committee of Sun Yat-sen University (approval number IACUC-DB-16-0202, Guangzhou, China). Diabetes was induced by intraperitoneal administration of 50 mg/kg STZ (Sigma-Aldrich, St. Louis, MO) dissolved in citrate buffer solution (0.1 mM, pH 4.5) to male Sprague-Dawley (SD) rats weighing 220 ~280 g , which were fasted overnight. A week after STZ administration, rats were fasted for 6 hours and blood was obtained by cutting tail tips to measure the glycemic level with a blood glucose meter (Abott). Rats were considered diabetic when fasting blood glucose levels were >14 mmol/L. Diabetic rats were fed with sufficient normal diet and water ad libitum and raised for another 8 weeks before being subjected to surgery.
2.2. In Vivo Experiment Protocol
To illustrate HIRI under hyperglycemic settings, normal and diabetic rats of the same weight range (140–150 g) were randomly distributed into 4 groups ( per group): (1) normal sham group; (2) diabetic sham group; (3) normal HIRI group; (4) diabetic HIRI group.
To determine the role of ROS during HIRI in diabetic rats, two classic antioxidants, NAC (300 mg/kg) and NAPDH oxidase inhibitor apocynin (2.5 mg/kg), were dissolved in normal saline and were administered intraperitoneally 1 h before the surgery separately. Confirmed diabetic rats were randomly distributed into 4 groups ( per group): (1) diabetic sham group; (2) diabetic HIRI group; (3) diabetic NAC group; (4) diabetic apocynin group.
2.3. Partial Hepatic Ischemia Reperfusion
General anesthesia was induced in all the rats by continuous spontaneous inhalation of 2%~5% volatile anesthetic isoflurane via a mask. After laparotomy, all vessels (hepatic artery, portal vein, and bile duct) to the left and median liver lobes were clamped, according to a previously described method . After 60 min of liver partial ischemia, these vessels were unclamped, and then the abdomen was closed and rats were revived to allow hepatic circulation to be restored for a reperfusion period of 6 hours. Rats were then anesthetized again before being sacrificed by withdrawal of blood from abdominal aorta. The blood collected was centrifuged at 3000 rpm for 10 minutes for serum. The left and median liver lobes were collected for histology and protein extraction described in the following paragraphs.
Liver paraffin-embedded sections stained were prepared as described previously . Histological severity of HIRI was graded using Suzuki’s criteria, in which sinusoidal congestion, hepatocyte necrosis, and ballooning degeneration are grated from 0 to 4. The absence of necrosis, congestion, or centrilobular ballooning is given a score of 0, whereas severe congestion, ballooning degeneration, and >60% lobular necrosis are given a value of 4 .
2.5. Serum Transferase Activities
The serum alanine transferase (AST) and aspartate transferase (ALT) activities were measured by using the Infinity™ AST (GOT) Liquid Stable Reagent and Infinity ALT (GPT) Liquid Stable Reagent (Thermo Fisher Scientific Inc.), respectively, according to the manufacturer’s instructions. Briefly, 30 μL of serum was mixed with 300 μL of reagent in a 96-well plate and the absorbance at 340 nm was measured with a microplate reader from 1 to 3 minutes. The AST/ALT activity was calculated with the following formula: the activity in = ( Absorbance/min) × 1746.
2.6. Serum H2O2 Activities
Serum H2O2 activities were assessed using KeyGEN H2O2 Assay Reagent Kit (KGT018, KeyGEN, Nanjing, China) according to manufacturer’s instruction. Briefly, 100 μL of sample, distilled water, or standard H2O2 solution was, respectively, mixed with the reagent provided in the kit in a required order and reacted for 1 minute. Absorbance at 405 nm was measured with a microplate reader and the H2O2 activity was calculated with the following formula: H2O2 (mmol/L) = .
2.7. Whole Cell Lysate (WCL)
WCL of liver and hepatocytes were extracted using KeyGEN WCL Assay Kit according to the manufacturer’s instruction (KGP2100, KeyGEN, Nanjing, China). Lysis was performed on ice for 15 min, and cell debris was removed by centrifugation at 13,000 ×g at 4°C for 10 min (5810R, Eppendorf AG). The supernatant was recovered as WCL and stored at −80°C.
2.8. Hepatic Malondialdehyde (MDA)
Hepatic MDA was assessed with WCL of liver tissues following the instruction of the manufacturer of KeyGEN MDA Assay Reagent Kit (KGT004, KeyGEN, Nanjing, China). Briefly, 200 μL of homogenized liver samples was mixed with the reagent provided in the kit and was processed in boiled water and then ice as stated in the instruction. The sample was then centrifuged and the supernatant was collected for measurement. Absorbance at 532 nm was obtained by a microplate reader.
2.9. Immunohistochemistry Staining
Liver paraffin-embedded sections were stained for 8-hydroxydeoxyguanosine (8-OHdG) to evaluate oxidative stress within hepatocytes. The samples were deparaffinized and incubated with monoclonal mouse 8-OHdG Ab (sc-66036, Santa Cruz Biotechnology, Inc.). The integrated optical intensity (IOD) of 8-OHdG (+) within the nuclei of hepatocytes was evaluated by Image-Pro Plus 6.0 (Media Cybernetics, Inc.).
2.10. Cell Culture
Normal rat hepatocytes BRL-3A were obtained from the Cell Bank of Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences (category number GNR10) and cultured in low glucose DMEM (Hyclone) containing 10% fetal bovine serum and supplemented with 100 U/mL penicillin and 100 μg/mL streptomycin in a humidified atmosphere in 5% CO2 at 37°C. Cells were plated and incubated overnight, before being used in experiment.
2.11. Hypoxia/Reoxygenation (H/R)
Cells were seeded and incubated overnight. The medium was replaced by serum-free nonglucose DMEM (Gibco, Thermo Fisher Scientific Inc.). Cellular hypoxic conditions were created and maintained in an airtight incubator (Galaxy 48R, Eppendorf Company) by continuous gas flow with a 95% N2 and 5% CO2 gas mixture, enabling the percentage of O2 to fall to 1% in 15 minutes. After 4 hours of hypoxia, 4 hours of reoxygenation was achieved by continuously flushing with a 95% air and 5% CO2 gas mixture and the glucose in the medium was restored.
2.12. High Glucose Culture
24 hours after cell plating, the culture media were replaced with a serum-free medium containing 5.5 mM or 25 mM D-glucose. The low glucose culture medium containing 5.5 mM D-glucose was supplemented with 19.5 mM mannitol (Amresco) to adjust the total osmotic pressure to 25 mM. For various purposes, the incubation continued for 6, 24, 48, 72, 96, 120, or 144 hours. As for H/R experiment, cells were incubated in serum-free mediums containing either 5.5 mM or 25 mM D-glucose (the osmotic pressure of which had been balanced as previously stated) for 6 hours before being subjected to hypoxia. At the end of treatment the cells or medium were harvested.
2.13. Nuclear Extract Preparation
Cells were washed twice with ice-cold PBS and scraped off from dishes with a rubber cell lifter. Nuclear extracts were prepared according to the instruction of NE-PER Nuclear & Cytoplasmic Extraction Reagent Kit (78833, Thermo Fisher Scientific Inc.). After being extracted, the nuclear and cytoplasmic protein was stored at −80°C.
2.14. Cell Viability
Cell viability was assessed by the CCK-8 test (KGA317, KeyGEN, Nanjing, China). Cells were seeded at 1 × 105 into 96-well-plates. After the indicated treatments, 10 μL CCK-8 solution at a 1/10 dilution was added to each well and then the plate was incubated for 2 hours in the incubator. Absorbance at 450 nm was measured with a microplate reader: cell viability (%) = (OD treatment group/OD control group) × 100%.
2.15. Cell Cytotoxicity
Cell cytotoxicity was assessed by determining released lactate dehydrogenase (LDH) into the medium by necrotic cells, using Pierce LDH Cytotoxicity Assay Kit (88953, Thermo Fisher Scientific Inc.) according to manufacturer’s instruction. Briefly, cultured cells underwent previously stated glucose culture and H/R procedure and subsequently released LDH into the medium after H/R. The medium was transferred to a new plate and mixed with reaction mixture. After 30-minute room temperature incubation, reactions were stopped by adding Stop Solution. Absorbance at 490 nm and 680 nm was measured using a plate-reading spectrophotometer to determine LDH activity. To determine LDH activity, the 680 nm absorbance value (background signal from instrument) was subtracted from the 490 nm absorbance.
ROS levels were determined using 6-carboxy-2′7′-dichlorodihydrofluorescein diacetate (DCFH-DA) (D6883, Sigma-Aldrich, St. Louis, MO). Cells were washed with ice-cold PBS and incubated with 10 μM DCFH-DA for 30 min. Then, the medium was discarded and cells were washed with ice-cold PBS in the dark, and ROS generation was evaluated by the fluorescence intensity measured by fluorescence spectrometry (SpectraMax M5, Molecular Devices, USA). The excitation wavelength was 504 nm and emission wavelength was 529 nm.
2.17. Enzyme-Linked Immunosorbent Assay (ELISA)
Rat-specific ELISA kits were applied to determine hepatic and medium tumor necrosis factor α (TNF-α, SEA133Ra, USCN, Cloud-Clone Corp., Wuhan, China), monocyte chemokine protein-1 (MCP-1, SEA087Mi, USCN, Cloud-Clone Corp., Wuhan, China), and hepatic interleukin-6 (IL-6, SEA079Ra, USCN, Cloud-Clone Corp., Wuhan, China) and levels according to the manufacturer’s instructions. Absorbance all measured at 450 nm. Hepatic 8-isoprostane level was determined using Cayman: 8-Isoprostane EIA Kit (number 516351, Cayman Chemical, USA) according to the manufacturer’s instruction. The absorbance was measured at a wave length of 420 nm.
2.18. Western Blotting Assays
Western blotting assays were performed as described before . Briefly, liver or hepatocyte WCL or nucleus extract were collected and the protein concentration was measured by Bradford assay. The samples were subjected to electrophoresis and transformation to polyvinylidene fluoride membranes. These membranes were blocked in 5% milk for 1 h, incubated with different primary antibodies overnight at 4°C, and then rinsed and incubated with secondary horseradish peroxidase-conjugated antibody for 1 h at room temperature. Antigen antibody complexes were then visualized using ECL kit (35050, Thermo Scientific Inc.).
The primary antibodies used here include those against nuclear factor-erythroid 2-related factor 2 (Nrf2, 1 : 1000, Abcam, Cambridge, MA), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB, 1 : 1000, Cell Signaling Technology (CST), Danvers, MA), total NF-κB inhibitor, alpha (IκBα, 1 : 2000, CST), phosphor-IκBα (1 : 500, CST), heme oxygenase-1 (HO-1, 1 : 250, Santa Cruz), and NAD(P)H:quinone oxidoreductase 1 (NQO1, 1 : 250, Santa Cruz).
2.19. Statistical Analysis
Results were processed by SPSS 13.0 (SPSS Inc.). Measurable data are expressed as means ± standard error of the mean (SEM). Pathological scores are expressed as median with interquartile range. Statistical analyses of measurable data were performed with the independent -test, and we performed Mann-Whitney test to analyze pathological scores. A value less than 0.05 was considered significant.
3.1. Hyperglycemia Aggravates HIRI in Diabetic Rats
Behrends et al. have proved that acute hyperglycemia induced by single intraperitoneal injection of glucose could worsen HIRI . To establish a more stable hyperglycemia model, we adopted STZ-induced type 1 diabetes model to intensively study the effect of glucose overload. We measured the glycemic level of normal and diabetic rats subjected to sham or partial hepatic I/R, respectively, and confirmed consistent significant hyperglycemia in STZ-induced diabetic rats compared to normal rats (Table 1). There were no significant differences with regard to hepatic histological findings between diabetic sham group and normal sham group (Figures 1(a) and 1(b)). However, when subjected to IR, more severe hepatocyte necrosis, sinus congestion, and hepatocyte ballooning were observed in diabetic group (Figures 1(a) and 1(b), ). The trend of serum ALT and AST was consistent with histological findings (Figures 1(c) and 1(d), ), which also indicated that hyperglycemia resulted in more serious HIRI.
3.2. Hyperglycemia Increases Baseline Lipid Peroxidation and Inflammatory Cytokines in Diabetic Rats and Further Aggravated Them after HIRI
The unifying hypothesis of diabetic complication places ROS at the center of the deleterious effect of hyperglycemia . Liver is particularly prone to oxidative/nitrosative stress due to its high metabolic rate and because hepatocytes are rich in ROS/RNS-producing mitochondria, cytochrome P450 (CYP) enzymes, and inducible nitric oxide synthase (iNOS). Increased oxidative/nitrosative stress has been a key contributor of hepatopathology relevant to diabetes such as NAFLD, viral hepatitis, and alcoholic fatty liver disease . So we found it necessary to determine the extent of oxidative stress between diabetic and normal rats.
As shown in Figure 2, serum H2O2 and nuclear 8-OHdG were higher in diabetic HIRI group compared to normal HIRI group (Figures 2(a) and 2(b), ) which implicated excessive ROS generation and consequent aggravated DNA injury in diabetic rats. The baseline level of lipid peroxidation product, hepatic 8-isoprostane and MDA, increased significantly in diabetic rats compared to normal rats and soared after IR (Figures 2(c) and 2(d), ).
Subclinical inflammation has also been reported among the basic changes within diabetic patients . We determined several common inflammatory cytokines including MCP-1, IL-6, and TNF-α in hepatic WCL, and it turned out they were also significantly higher in diabetic rats and further increased after IR (Figure 2(e), ).
3.3. High Glucose Culture before H/R Increased the Vulnerability of BRL-3A Hepatocytes to H/R Injury
We subjected BRL-3A hepatocytes to 5.5 mM and 25 mM of D-glucose culture for 6–96 hours, and it turned out that the cell viability of BRL-3A was similar between 2 groups in normoxic environment (Figure 3(a)). However, after H/R, the viability of BRL-3A hepatocytes was significantly hampered after 6, 24, 48, 72, and 96 hours of 25 mM glucose pretreatment (Figure 3(b), ). H/R could comparably increase the LDH leakage in both groups (Figure 3(c)).
3.4. High Glucose Culture Increased ROS and Cytokines under Normoxic Settings and Further Elevated Them after H/R
It has been proposed that excessive glucose induces ROS in endothelial cells mainly by activation of protein kinase C isoforms, increased formation of glucose-derived advanced glycation end-products (AGEs), and increased glucose flux through the aldose reductase pathway or polyol pathways [36, 37]. Here we demonstrated in hepatocytes that ROS generation was also increased after 25 mM glucose culture. H/R stress resulted in excessive production of ROS in both 5.5 mM and 25 mM glucose pretreated group. However, the fluorescent intensity of ROS was significantly higher and further enhanced after H/R in 25 mM group compared to 5.5 mM group (Figures 4(a) and 4(b), ). This implicates that the stress of acute H/R can amplify existing oxidative stress induced by excessive glucose, therefore causing more severe HIRI compared to control.
As has been observed in in vivo HIRI models, inflammatory cytokines, including MCP-1 and TNF-α in culture medium, were both significantly increased after exposure to 25 mM D-glucose under normoxic settings as well (Figures 4(c) and 4(d), ). After H/R, in 25 mM pretreated cells, TNF-α was significantly higher compared to 5.5 mM group (Figure 4(c), ).
3.5. High Glucose Culture Triggered NF-κB Translocation within Normoxic and Hypoxic-Redox BRL-3A Cells
Besides direct damage to cell components, ROS are also pivotal signals in various cellular pathways including NF-κB pathway . NF-κB is an important transcription factor that reacts to redox signals and regulates the expression of many inflammatory cytokines including MCP-1, IL-6, and TNF-α [39, 40]. Compared with 5.5 mM group, IκBα phosphorylation and nuclear NF-κB were higher before H/R after 6 hours of 25 mM D-glucose culture (Figure 5(a), ), which explained the consistently increased cytokines in medium. After H/R, the nuclear NF-κB in 25 mM H/R group was significantly increased compared to 5.5 mM H/R group (Figure 5(b), ). Thus, high glucose culture before H/R not only could accelerate NF-κB activation but also increased the translocation of NF-κB after H/R. The subsequently upregulated proinflammatory cytokines could activate neutrophils and Kupffer cells to trigger profound cytotoxic immune response .
3.6. High Glucose Culture Activated Nrf2 Translocation within Normoxic and Hypoxic-Redox BRL-3A Cells without Affecting the Expression of NQO1 and HO-1
Nrf2 is another redox-sensitive transcription factor that mainly regulates the expression of antioxidases including HO-1 and NQO1 to counter harmful stimuli including ROS . Here we demonstrated in BRL-3A hepatocytes that nuclear Nrf2 was significantly higher before H/R after 6 hours of 25 mM D-glucose culture compared with 5.5 mM group (Figure 6(a), ). Nevertheless, as downstream oxidase of Nrf2, the expression of NQO1 and HO-1 was comparable between low and high glucose pretreated groups. Consistently, while NQO1 and HO-1 were upregulated after H/R in 5.5 mM H/R group compared to normoxic control, they remained unaffected in 25 mM H/R group (Figure 6(b)).
3.7. NAC and Apocynin Pretreatment Ameliorated HIRI and Oxidative Stress and Inflammation
With these findings, we postulate that ROS lies in the center of the amplified inflammation cascades and aggravated HIRI. ROS scavengers including NAC and apocynin have been suggested to be a solution to ameliorate or reverse the deleterious effect of overly triggered oxidative stress [43, 44]. N-Acetyl-cysteine serves as a prodrug to L-cysteine, which is a precursor to the biologic antioxidant glutathione. Hence, administration of NAC replenishes reduced glutathione (GSH) . The GSH synthesis is controlled by the activity of γ-glutamyl cysteine ligase (γ-GCL) and by the availability of cysteine. γ-GCL is composed of two subunits: the glutamate-cysteine ligase complex modifier subunit (GCLM) and the GCL catalytic subunit (GCLC). Nrf2 regulates the expression of these subunits . Apocynin is an inhibitor of NADPH oxidase activity and thus is effective in preventing reduction of O2 to superoxide (), in human neutrophilic granulocytes. We intended to examine whether HIRI in diabetic rats could be ameliorated by either partial restoration of hampered Nrf2 pathway or suppression of ROS generation.
In the present study, we found out that NAC and apocynin administered intraperitoneally before IR could both ameliorate HIRI in diabetic rats, indicated by lower pathological scores and lower serum ALT and AST (Figures 7(a) and 7(b), ). NAC and apocynin pretreatment could also lower the expressions of hepatic IL-6, MCP-1, and TNF-α (Figure 7(c), ) compared with HIRI group. The nuclear 8-OHdG significantly decreased in NAC and apocynin pretreated group compared with HIRI group (Figures 7(d) and 7(e), ). The same went for hepatic 8-isoprostane and MDA (Figures 7(f) and 7(g), ), which indicated a decrease in lipid peroxidation.
Hyperglycemia alone under normoxic condition does not significantly impact the viability of hepatocytes. Chen et al. demonstrated that Chang liver cells in mannitol-balanced 5.5 mM, 25 mM, and 100 mM glucose media after at least 3 weeks showed no significant variation in viability and apoptosis among the three culture conditions . However, hyperglycemia is associated with chronic oxidative stress . In the cardiac tissues of both type 1 and type 2 diabetes, an elevated baseline of ROS induced by hyperglycemia was identified . Glucose induce ROS mainly by activation of protein kinase C isoforms, increased formation of glucose-derived advanced glycation end-products (AGEs), and increased glucose flux through the aldose reductase pathway or polyol pathways [36, 37]. Consistently, the present study demonstrated that both in vivo and in vitro high glucose exposure could increase baseline hepatic oxidative stress.
Chronic oxidative stress may promote the onset or progression of chronic liver diseases which if not treated properly are likely to advance to end-stage liver diseases requiring surgical intervention [20, 21]. However, little is known about the impact of chronic oxidative stress caused by hyperglycemia on HIRI. During reperfusion, enormous ROS are generated due to sudden restoration of oxygen and exert direct deleterious effects on cells through lipid peroxidation, protein degradation, and DNA damage . The present study demonstrated that hepatic oxidative stress was further exacerbated after HIRI or H/R in both in vivo and in vitro high glucose settings. In line with soaring ROS generation, hepatocytes in high glucose environment predisposed to HIRI or H/R injury demonstrated by higher pathological score and serum transferase or lower cell viability. This implicates that the stress of acute IR can amplify existing oxidative stress induced by glucose overloads, therefore causing more severe HIRI compared to control.
In addition to direct damage to cell components, ROS can also activate various cellular pathways including NF-κB pathway . The inactive NF-κB is sequestered in the cytoplasm with an inhibitor protein, IκB. In a conventional activation pathway, IκB is phosphorylated by IκB kinases (IKKs) in response to different activators, including ROS, and subsequently degraded thus liberating the active NF-κB complex to nucleus . We observed phosphorylated IκBα, increased NF-κB translocation into nucleus after high glucose culture before H/R, which explained the consistently increased cytokines in medium. The result of in vitro study was similar to that of in vivo study where hepatic cytokines increased at baseline and strikingly rose after IR in diabetic rats, suggesting high glucose induced activation of NF-κB might also be involved in HIRI in diabetic rats. Clinically NF-κB related cytokines, TNF-α, IL-6, and MCP-1, were found increased in patients with type 2 diabetes . These proinflammatory cytokines could activate neutrophils and Kupffer cells to trigger profound cytotoxic immune response .
Nrf2 is another redox-sensitive transcription factor that mainly regulates the expression of antioxidases including HO-1 and NQO1 to counter harmful stimuli including ROS . It has been reported that Nrf2 pathway activates in high glucose stimulated cardiomyocytes endothelial cells and renal mesenchymal cells as intrinsic defense against oxidative stress [42, 47, 48]. However, in our present study, high glucose could increase the Nrf2 translocation in hepatocytes but did not alter the expression of HO-1 and NQO1. Moreover, in contrast to its further increase and consequent upregulation of HO-1 and NQO1 after H/R in low glucose pretreated hepatocytes, nuclear Nrf2 in high glucose pretreated hepatocytes was not significantly increased following H/R and neither were its downstream antioxidases. The results implicate that the antioxidative ability of Nrf2 pathway might be hampered after high glucose exposure.
Recent evidence indicates that NF-κB may directly repress Nrf2 signaling at the transcription level [49, 50]. DNase I footprint assays using purified transcription factors revealed the presence of NF-κB and AP-2 binding sites in the proximal part of the promoter region of the human HO-1 gene . Therefore, it is reasonable to postulate that ROS overproduction by high glucose could initiate both NF-κB and Nrf2 activation, while the former prevailed and frustrated the function of Nrf2. However, the exact mechanisms of NF-κB and Nrf2 interaction under hyperglycemic settings remain to be further elucidated.
With these findings, we postulate that ROS lies in the center of the amplified inflammation cascades and aggravated HIRI. ROS scavengers including NAC and apocynin have been suggested to be a solution to ameliorate or reverse the deleterious effect of overly triggered oxidative stress [43, 44]. NAC and apocynin administered intraperitoneally before IR could ameliorate hepatic injury in diabetic rats along with decreased inflammatory cytokines, attenuated lipid peroxidation, and ROS-inflicted DNA injury compared with the HIRI controls. The present results are consistent with those of other researchers which reported the long-term oral administration of NAC and Allopurinol showed synergistic protective effect on diabetic ischemic cardiac tissues . It is therefore a promising strategy to alleviate HIRI by countering preoperative chronic oxidative stress in diabetes before IR.
One of the limitations of this study may lie in the choice of animal models used to represent chronic hyperglycemia. STZ-induced diabetes is a model of type 1 diabetes mellitus, within which the cause of hyperglycemia is attributed to insulin insufficiency due to STZ toxicity upon islet β-cells . The dosage, approach, and frequency of STZ administration vary in a broad range . In the current study, we chose to give a single dose of 50 mg/kg of STZ administered intraperitoneally, which is a considerably mild dose compared to those used in other studies. We provided sufficient normal diet and water for the confirmed diabetic rats and measured the fasting, random, and preoperative glycemic levels to prevent hypoglycemia. Since persistent hyperglycemia is a major manifestation of all kinds of diabetes, the primary aim of our study was to examine the impact of glucose excess on HIRI.
Another issue that might be of concern is the potential protection of insulin in hyperglycemia induced aggravation of HIRI. Insulin is undoubtedly the first-line treatment for preoperative and intraoperative hyperglycemia. Preoperative insulin treatment is definitely effective in compensating β-cell function and lowering blood glucose in STZ-induced type 1 diabetic models. Rocha et al. demonstrated that insulin led to the significant reduction of the serum concentration of AST, ALT, gamma-glutamyl transferase (GGT), and LDH in rat HIRI model. Nevertheless, these beneficial effects were found to be independent from blood glucose levels and may have been attributed to inhibition of GSK-3β . Our focus of the current study, however, was mainly on the role of hyperglycemia, as an initial trigger of chronic oxidative stress, which will lead to further exacerbation of I/R injury. However, persistent hyperglycemia is very common when surgical stress is imposed upon diabetic patients, sometimes even in normal patients, since the secretion of catecholamine would aggravate insulin resistance, thus reducing the efficacy of exogenous insulin infusion. Moreover, the attempt to lower blood glucose might not be enough or in time to reverse the deleterious effects, for instance, the formation of excessive ROS and amplified inflammation, which are already imposed on the rendered liver. Therefore, we intended to find a solution to ameliorate the consequence caused by high glucose as it may be more practical in the context of surgery. Nevertheless, we cannot deny the potential protection offered by insulin during the preoperative preparation, which has proven to be very meaningful for the timing of elective surgery on diabetic patients. We will conduct more researches to study the effect of insulin-related pathways on diabetic HIRI in the future.
In summary, we demonstrated that hyperglycemia could aggravate HIRI, and the exacerbation was related to chronic oxidative stress and inflammation induced by excessive glucose (Figure 8). The amplified inflammation may be attributed to NF-κB translocation most probably induced by chronic oxidative stress. Hampered antioxidative ability of Nrf2 pathway may also be involved in aggravated HIRI after high glucose exposure. Inhibitory interaction between NF-κB and Nrf2 at transcription level may be a possible explanation, though the exact mechanisms of the interaction of these two transcription factors under hyperglycemic settings remain to be studied. Antioxidant precondition may be a potential therapy to alleviate diabetic HIRI.
There are no conflicts of interest for any of the authors.
Ziqing Hei and Xinjin Chi contributed equally as corresponding authors. Ziqing Hei, Xinjin Chi, and Yong Huang worked jointly in designing this experiment. Yihan Zhang and Dongdong Yuan contributed equally in major experiment procedure and thesis writing. Yihan Zhang, Weifeng Yao, and Xi Chen cooperated in the establishment of animal models and consequent assessment. Dongdong Yuan, Yue Liu, and Fei Huang were major participants of in vitro researches. Yihan Zhang and Qianqian Zhu were mainly responsible for data analysis. All authors have read and approved the final manuscript.
This study is supported by the National Natural Science Foundation of China (Grant no. 81372090); Science and Technology Project of Guangdong Province (Grant no. 2013B051000035); Guangdong Natural Science Foundation (Grant no. 2014A030313193). The authors thank Professor Zhengyuan Xia for his insightful guidance in the establishment of STZ-induced diabetes rat model.
- S. Haga, S. J. Remington, N. Morita, K. Terui, and M. Ozaki, “Hepatic ischemia induced immediate oxidative stress after reperfusion and determined the severity of the reperfusion-induced damage,” Antioxidants and Redox Signaling, vol. 11, no. 10, pp. 2563–2572, 2009.
- B. F. Trump and I. K. Berezesky, “Calcium-mediated cell injury and cell death,” The FASEB Journal, vol. 9, no. 2, pp. 219–228, 1995.
- B. Vollmar, M. D. Menger, J. Glasz, R. Leiderer, and K. Messmer, “Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 267, no. 5, pp. G786–G793, 1994.
- N. G. Frangogiannis, “Chemokines in ischemia and reperfusion,” Thrombosis and Haemostasis, vol. 97, no. 5, pp. 738–747, 2007.
- N.-E. L. Saris and K. O. Eriksson, “Mitochondrial dysfunction in ischaemia-reperfusion,” Acta Anaesthesiologica Scandinavica, Supplement, vol. 39, no. 107, pp. 171–176, 1995.
- H. Jaeschke and B. L. Woolbright, “Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species,” Transplantation Reviews, vol. 26, no. 2, pp. 103–114, 2012.
- W. M. Ricci, P. N. Streubel, S. Morshed, C. A. Collinge, S. E. Nork, and M. J. Gardner, “Risk factors for failure of locked plate fixation of distal femur fractures: an analysis of 335 cases,” Journal of Orthopaedic Trauma, vol. 28, no. 2, pp. 83–89, 2014.
- B. A. Ponce, M. E. Menendez, L. O. Oladeji, and F. Soldado, “Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty,” Journal of Shoulder and Elbow Surgery, vol. 23, no. 5, pp. 671–678, 2014.
- M. Ardeshiri, Z. Faritus, Z. Ojaghi Haghighi, H. Bakhshandeh, F. Kargar, and R. Aghili, “Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery,” Research in Cardiovascular Medicine, vol. 3, no. 3, Article ID e20270, 2014.
- M. Ding, J. Lei, H. Han et al., “SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats,” Cardiovascular Diabetology, vol. 14, no. 1, article 143, 2015.
- J. Parekh, G. R. Roll, S. Feng, C. U. Niemann, and R. Hirose, “Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation,” Clinical Transplantation, vol. 27, no. 4, pp. E424–E430, 2013.
- M. Abdelsaid, R. Prakash, W. Li et al., “Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes,” Diabetes, vol. 64, no. 5, pp. 1804–1817, 2015.
- J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002.
- R. Ni, D. Zheng, S. Xiong et al., “Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type-1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy,” Diabetes, vol. 65, no. 1, pp. 255–268, 2016.
- H. Ha, R. Y. Mi, J. C. Yoon, M. Kitamura, and B. L. Hi, “Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells,” Journal of the American Society of Nephrology, vol. 13, no. 4, pp. 894–902, 2002.
- X. Cheng, R. C. M. Siow, and G. E. Mann, “Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway,” Antioxidants and Redox Signaling, vol. 14, no. 3, pp. 469–487, 2011.
- R. Badalzadeh, B. Mokhtari, and R. Yavari, “Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus,” Journal of Physiological Sciences, vol. 65, no. 3, pp. 201–215, 2015.
- H. S. Kim, J. E. Cho, K. C. Hwang, Y. H. Shim, J. H. Lee, and Y. L. Kwak, “Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival,” European Journal of Pharmacology, vol. 628, no. 1–3, pp. 132–139, 2010.
- H. O. Altunkaynak and A. T. Ozcelikay, “Cardioprotective effect of postconditioning against ischemia-reperfusion injury is lost in heart of 8-week diabetic rat,” General Physiology and Biophysics, vol. 35, no. 1, pp. 63–69, 2015.
- S. Bonapace, F. Valbusa, L. Bertolini et al., “Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus,” PLoS ONE, vol. 9, no. 2, Article ID e88371, 2014.
- J.-Y. Chen, H.-C. Chou, Y.-H. Chen, and H.-L. Chan, “High glucose-induced proteome alterations in hepatocytes and its possible relevance to diabetic liver disease,” Journal of Nutritional Biochemistry, vol. 24, no. 11, pp. 1889–1910, 2013.
- G. Zoppini, U. Fedeli, N. Gennaro, M. Saugo, G. Targher, and E. Bonora, “Mortality from chronic liver diseases in diabetes,” American Journal of Gastroenterology, vol. 109, no. 7, pp. 1020–1025, 2014.
- R. S. Hoehn, A. Singhal, K. Wima et al., “Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a National cohort study,” Liver International, vol. 35, no. 7, pp. 1902–1909, 2015.
- Z. M. Younossi, M. Stepanova, S. Saab et al., “The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US,” Alimentary Pharmacology and Therapeutics, vol. 40, no. 6, pp. 686–694, 2014.
- K. W. Brudvik, Y. Mise, C. Conrad, G. Zimmitti, T. A. Aloia, and J.-N. Vauthey, “Definition of readmission in 3,041 patients undergoing hepatectomy,” Journal of the American College of Surgeons, vol. 221, no. 1, pp. 38–46, 2015.
- A. C. C. Bragança and M. R. Álvares-Da-Silva, “Prevalence of diabetes mellitus and impaired glucose tolerance in patients with decompensated cirrhosis being evaluated for liver transplantation: the utility of oral glucose tolerance test,” Arquivos de Gastroenterologia, vol. 47, no. 1, pp. 22–27, 2010.
- X. Chen and W. Yang, “Epidemic trend of diabetes in China: for the Xiaoren Pan Distinguished Research Award in AASD,” Journal of Diabetes Investigation, vol. 5, no. 5, pp. 478–481, 2014.
- K. Huang, J. Huang, X. Xie et al., “Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells,” Free Radical Biology and Medicine, vol. 65, pp. 528–540, 2013.
- C. Liu, X. Wang, Z. Chen, L. Zhang, Y. Wu, and Y. Zhang, “Hepatic ischemia-reperfusion induces insulin resistance via down-regulation during the early steps in insulin signaling in rats,” Transplantation Proceedings, vol. 40, no. 10, pp. 3330–3334, 2008.
- M. Ge, W. Yao, Y. Wang et al., “Propofol alleviates liver oxidative stress via activating Nrf2 pathway,” Journal of Surgical Research, vol. 196, no. 2, pp. 373–381, 2015.
- C. Fondevila, X.-D. Shen, S. Tsuchihashi et al., “The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury,” Liver Transplantation, vol. 14, no. 8, pp. 1133–1141, 2008.
- M. Ge, X. Chi, A. Zhang et al., “Intestinal NF-E2-related factor-2 expression and antioxidant activity changes in rats undergoing orthotopic liver autotransplantation,” Oncology Letters, vol. 6, no. 5, pp. 1307–1312, 2013.
- M. Behrends, G. Martinez-Palli, C. U. Niemann, S. Cohen, R. Ramachandran, and R. Hirose, “Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats,” Journal of Gastrointestinal Surgery, vol. 14, no. 3, pp. 528–535, 2010.
- K. A. Lockman, J. P. Baren, C. J. Pemberton et al., “Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis,” Liver International, vol. 32, no. 7, pp. 1079–1092, 2012.
- G. Daniele, R. Guardado Mendoza, D. Winnier et al., “The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus,” Acta Diabetologica, vol. 51, no. 1, pp. 123–131, 2014.
- T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000.
- E. Schleicher and U. Friess, “Oxidative stress, AGE, and atherosclerosis,” Kidney International. Supplement, no. 106, pp. S17–S26, 2007.
- N. Y. Spencer, W. Zhou, Q. Li et al., “Hepatocytes produce TNF-α following hypoxia-reoxygenation and liver ischemia-reperfusion in a NADPH oxidase- and c-Src-dependent manner,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 305, no. 1, pp. G84–G94, 2013.
- M. J. Morgan and Z.-G. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, no. 1, pp. 103–115, 2011.
- M. Niwa, A. Hara, Y. Kanamori et al., “Nuclear factor-κB activates dual inhibition sites in the regulation of tumor necrosis factor-α-induced neutrophil apoptosis,” European Journal of Pharmacology, vol. 407, no. 3, pp. 211–219, 2000.
- R. F. Saidi and S. K. H. Kenari, “Liver ischemia/reperfusion injury: an overview,” Journal of Investigative Surgery, vol. 27, no. 6, pp. 366–379, 2014.
- M. O. Leonard, N. E. Kieran, K. Howell et al., “Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury,” The FASEB Journal, vol. 20, no. 14, pp. 2624–2626, 2006.
- M. M. Lasram, I. B. Dhouib, A. Annabi, S. El Fazaa, and N. Gharbi, “A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development,” Clinical Biochemistry, vol. 48, no. 16-17, pp. 1200–1208, 2015.
- A. Ceriello, “New insights on oxidative stress and diabetic complications may lead to a ‘causal’ antioxidant therapy,” Diabetes Care, vol. 26, no. 5, pp. 1589–1596, 2003.
- K. Aquilano, S. Baldelli, and M. R. Ciriolo, “Glutathione: new roles in redox signalling for an old antioxidant,” Frontiers in Pharmacology, vol. 5, article 196, 2014.
- D. L. Severson, “Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes,” Canadian Journal of Physiology and Pharmacology, vol. 82, no. 10, pp. 813–823, 2004.
- P. Palsamy and S. Subramanian, “Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1812, no. 7, pp. 719–731, 2011.
- L. Cominacini, C. Mozzini, U. Garbin et al., “Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases,” Free Radical Biology and Medicine, vol. 88, pp. 233–242, 2015.
- M. Buelna-Chontal and C. Zazueta, “Redox activation of Nrf2 & NF-κB: a double end sword?” Cellular Signalling, vol. 25, no. 12, pp. 2548–2557, 2013.
- G.-H. Liu, J. Qu, and X. Shen, “NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1783, no. 5, pp. 713–727, 2008.
- Y. Lavrovsky, M. L. Schwartzman, R. D. Levere, A. Kappas, and N. G. Abraham, “Identification of binding sites for transcription factors NF-κB and AP-2 in the promoter region of the human heme oxygenase 1 gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 5987–5991, 1994.
- T. Wang, S. Qiao, S. Lei et al., “N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats,” PLoS ONE, vol. 6, no. 8, Article ID e23967, 2011.
- A. J. F. King, “The use of animal models in diabetes research,” British Journal of Pharmacology, vol. 166, no. 3, pp. 877–894, 2012.
- T. Szkudelski, “Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model,” Experimental Biology and Medicine, vol. 237, no. 5, pp. 481–490, 2012.
- J. Rocha, M.-E. Figueira, A. Barateiro et al., “Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat,” Shock, vol. 43, no. 4, pp. 369–378, 2015.
Copyright © 2016 Yihan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.